Survival of preterm babies has increased worldwide. Recent studies have focused on outcomes of extremely preterm children (born at 22-26 weeks' gestation), but outcomes of children born very and moderately preterm (between ...
Aug 16, 2017
0
92
(HealthDay)—De novo KCNB1 missense and loss-of-function variants are associated with neurodevelopmental disorders, with or without seizures, according to a study published online Aug. 14 in JAMA Neurology.
Aug 16, 2017
0
12
In the first major study of its kind, researchers using MRI have identified structural abnormalities in the brains of people with one of the most common genetic causes of autism, according to a new study published online ...
Aug 8, 2017
0
16
Because of genetic testing, Orion Maynard's parents knew the cause of his epilepsy weeks after he was born. The results influenced his treatment, qualified him for immediate intervention services and led to the discovery ...
Aug 3, 2017
0
5
Early intervention services for children with disabilities or developmental delays are focused on being family centered and are ideally conducted in the home setting. Even so, fathers—custodial or noncustodial—are often ...
Aug 2, 2017
0
1
Last week, German customs agents in Frankfurt Airport seized 35 metric tons of an imported plastic device, destroying the shipment for public safety purposes before it could infiltrate the country's marketplaces.
Jun 21, 2017
0
8
Georgetown University Medical Center autism specialists working with Latino families in Washington, DC, have developed an effective screening program that identifies Latino infants who may be at risk for autism spectrum disorder ...
May 10, 2017
0
3
A clinical trial of a drug that researchers hope can prevent or delay the onset of epilepsy in children with tuberous sclerosis has begun at McGovern Medical School at The University of Texas Health Science Center at Houston ...
May 8, 2017
0
2
As the number of smart phones, tablets, electronic games and other handheld screens in U.S. homes continues to grow, some children begin using these devices before beginning to talk. New research being presented at the 2017 ...
May 4, 2017
0
199
(HealthDay)—Brineura (cerliponase alfa) has been approved by the U.S. Food and Drug Administration to treat a specific form of Batten Disease, a rare set of genetic disorders that typically begin in childhood between ages ...
Apr 28, 2017
0
2
